FMED | IBB | FMED / IBB | |
Gain YTD | -2.922 | -3.545 | 82% |
Net Assets | 52M | 5.25B | 1% |
Total Expense Ratio | 0.50 | 0.45 | 111% |
Turnover | 33.00 | 22.00 | 150% |
Yield | 0.48 | 0.32 | 153% |
Fund Existence | 5 years | 24 years | - |
FMED | IBB | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 3 days ago75% | 3 days ago90% |
Momentum ODDS (%) | 3 days ago76% | 3 days ago90% |
MACD ODDS (%) | 3 days ago84% | 3 days ago90% |
TrendWeek ODDS (%) | 3 days ago79% | 3 days ago87% |
TrendMonth ODDS (%) | 3 days ago84% | 3 days ago85% |
Advances ODDS (%) | 20 days ago81% | 16 days ago86% |
Declines ODDS (%) | 6 days ago80% | 3 days ago85% |
BollingerBands ODDS (%) | 3 days ago90% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago87% | 3 days ago84% |
A.I.dvisor indicates that over the last year, FMED has been loosely correlated with NTLA. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if FMED jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To FMED | 1D Price Change % | ||
---|---|---|---|---|
FMED | 100% | +2.48% | ||
NTLA - FMED | 65% Loosely correlated | +3.68% | ||
TECH - FMED | 61% Loosely correlated | +1.42% | ||
DNLI - FMED | 60% Loosely correlated | +5.73% | ||
TMO - FMED | 60% Loosely correlated | +1.04% | ||
TXG - FMED | 60% Loosely correlated | +0.93% | ||
More |
A.I.dvisor indicates that over the last year, IBB has been closely correlated with IQV. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBB jumps, then IQV could also see price increases.
Ticker / NAME | Correlation To IBB | 1D Price Change % | ||
---|---|---|---|---|
IBB | 100% | +1.98% | ||
IQV - IBB | 75% Closely correlated | +2.20% | ||
KRYS - IBB | 68% Closely correlated | +4.17% | ||
IDYA - IBB | 67% Closely correlated | +1.68% | ||
ROIV - IBB | 66% Closely correlated | +0.35% | ||
TECH - IBB | 65% Loosely correlated | +1.42% | ||
More |